Clinigen is a Global specialty pharmaceuticals and services business, supplying clinical trial, licensed and unlicensed critical, life saving drugs. Our focus is on getting the Right Drug to The Right Patient at the Right time.
There are three distinct operating businesses which benefit from important synergies between them:
Clinigen CTS - Partnering with suppliers and sourcing drugs for use in clinical trials.
Clinigen GAP - Supplying unlicensed or yet to be licensed drugs to patient needs via their physicians.
Clinigen SP – A portfolio of oncology support and infectious disease medicines through selectively acquiring niche, hospital-based or emergency medicines.
With our Global network serving c.75+ countries with a broad, blue chip customer base of global pharmaceutical/biotech companies and contract research organisations, Clinigen is a highly profitable, cash-generative business with impressive continuous growth over the past five years.
Our global head office is in Burton on Trent along with the Operations Centre and offices are located in the USA and Japan.
Clinigen joined the LMA Community partnership in 2014 and is looking forward to working with the LMA on the Sports Science Master Class and local schools involved.
Click here to view the 2018/19 Clinigen Newsletter.
Contact Details – Shaun Chilton, COO -Clinigen Group plc,
Tel. 01283 494 326
Website for further info – www.clinigengroup.com